You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HBsAg

Showing 1 - 25 of 928
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HBsAg Declined Patients Follow-up Study

Not yet recruiting
  • Hepatitis B
  • Hepatitis B, Chronic
    • (no location specified)
    Jul 28, 2023

    Hepatitis B Trial in Cambridge (GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide, GSK's HBsAg candidate vaccine

    Recruiting
    • Hepatitis B
    • GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide
    • +4 more
    • Cambridge, United Kingdom
      GSK Investigational Site
    Jan 12, 2023

    Chronic Hepatitis B Trial in Zhengzhou (PegIFN a- 2b)

    Completed
    • Chronic Hepatitis B
    • PegIFN α- 2b
    • Zhengzhou, Henan, China
      Henan Provincial People's Hospital
    Jul 11, 2022

    Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes

    Recruiting
    • Hepatitis B
      • Sabadell, Barcelona, Spain
        H. Consorci Sanitari Parc Tauli
      Jul 5, 2022

      Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Sorafenib, Lenvatinib)

      Recruiting
      • Hepatocellular Carcinoma
      • Hong Kong, Hong Kong SAR, Hong Kong
        Humanity & Health Research Centre
      Mar 16, 2022

      Kidney Transplantation, HBV Trial in Chengdu (prophylaxis regimen)

      Recruiting
      • Kidney Transplantation
      • HBV
      • prophylaxis regimen
      • Chengdu, Sichuan, China
        Tao Lin
      Jul 21, 2021

      Chronic Hepatitis b Trial in Guangzhou (Vitamin D)

      Completed
      • Chronic Hepatitis b
      • Vitamin D
      • Guangzhou, Guangdong, China
        Department of Infectious Diseases, The Third Affliated Hospital
      Mar 2, 2023

      Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNa Trial in Chongqing (Anti-PD-1 antibody, NAs, Peg-IFNa)

      Not yet recruiting
      • Chronic Hepatitis b
      • +2 more
      • Anti-PD-1 antibody
      • +2 more
      • Chongqing, Chongqing, China
        The 2nd affiliated Hospital of Chongqing Medical University
      Mar 14, 2023

      Chronic Hepatitis b, Anti-PD-1 Antibody Trial in Chongqing (Anti-PD-1 antibody, NAs)

      Not yet recruiting
      • Chronic Hepatitis b
      • Anti-PD-1 Antibody
      • Anti-PD-1 antibody
      • NAs
      • Chongqing, Chongqing, China
        The 2nd affiliated Hospital of Chongqing Medical University
      Mar 3, 2023

      Chronic Hepatitis B Trial in Zhengzhou (continuous treatment, pulse therapy)

      Recruiting
      • Chronic Hepatitis B
      • continuous treatment
      • pulse therapy
      • Zhengzhou, Henan, China
        Henan Provincial People's Hospital
      Jul 13, 2022

      HBV, Inflammatory Arthritis Trial (Tenofovir alafenamide)

      Not yet recruiting
      • HBV
      • Inflammatory Arthritis
      • Tenofovir alafenamide
      • (no location specified)
      Aug 5, 2021

      Chronic Hepatitis B Trial in Beijing (PEG-IFN)

      Recruiting
      • Chronic Hepatitis B
      • Beijing, Beijing, China
        Department of Hepatology Division 2, Beijing Ditan Hospital
      May 9, 2022

      Chronic Hepatitis B Trial in Hannover (Human hepatitis B Immunoglobulin (Hepatect®CP/Zutectra®))

      Recruiting
      • Chronic Hepatitis B
      • Human hepatitis B Immunoglobulin (Hepatect®CP/Zutectra®)
      • Hannover, Lower Saxony, Germany
        Hannover Medical School, Department for Gastroenterology, Hepato
      May 31, 2022

      Hepatitis B, Chronic Trial in Worldwide (Entecavir (ETV), Tenofovir Disoproxil Fumarate (TDF), Tenofovir Alafenamide (TAF))

      Withdrawn
      • Hepatitis B, Chronic
      • Entecavir (ETV)
      • +2 more
      • Kolding, Denmark
      • +29 more
      Oct 27, 2022

      Hepatitis B Reactivation Trial in Chiayi City, Tainan, Yun-Lin (Tenofovir alafenamide)

      Recruiting
      • Hepatitis B Reactivation
      • Tenofovir alafenamide
      • Chiayi City, Taiwan
      • +4 more
      Apr 26, 2022

      Hepatitis B Trial in Baltimore, Falls Church (Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B])

      Withdrawn
      • Hepatitis B
      • Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
      • Baltimore, Maryland
      • +1 more
      Jul 19, 2022

      Hepatitis B Trial in France (inactive carrier)

      Completed
      • Hepatitis B
      • inactive carrier
      • Aix en Provence, France
      • +31 more
      Apr 5, 2022

      Hepatocellular Carcinoma Trial in Xuzhou (fhB7H3.CAR-Ts, Fludarabine, Cyclophosphamide)

      Recruiting
      • Hepatocellular Carcinoma
      • fhB7H3.CAR-Ts
      • +2 more
      • Xuzhou, Jiangsu, China
        The Affiliated Hospital of Xuzhou Medical University
      Apr 5, 2022

      Hepatitis B, HIV Trial in Worldwide (Selgantolimod, Placebo)

      Recruiting
      • Hepatitis B
      • HIV Infections
      • San Diego, California
      • +35 more
      Jan 31, 2023

      Hepatitis B and Hepatitis C (Disorder) Trial in Chongqing (education, no education)

      Completed
      • Hepatitis B and Hepatitis C (Disorder)
      • education
      • no education
      • Chongqing, Chongqing, China
        The 2nd affiliated Hospital of Chongqing Medical University
      Jan 16, 2021

      Hepatitis B, Liver Transplantation Trial in New York (Adefovir dipivoxil and hepatitis B vaccination)

      Completed
      Has Results
      • Hepatitis B
      • Liver Transplantation
      • Adefovir dipivoxil and hepatitis B vaccination
      • New York, New York
        Center for Liver Disease and Transplantation at Columbia Univers
      Aug 6, 2021

      Liver Fibrosis Trial (PEG-Interferon Alfa, Tenofovir Disoproxil Fumarate, Tenofovir Disoproxil Fumarate)

      Not yet recruiting
      • Liver Fibrosis
      • PEG-Interferon Alfa, Tenofovir Disoproxil Fumarate
      • Tenofovir Disoproxil Fumarate
      • (no location specified)
      Nov 17, 2020

      Predictive Model for Prognosis of Chronic HBV Infection Mothers

      Recruiting
      • Hepatitis B, Chronic
      • Age, BMI,Baseline HBV DNA, Baseline HBeAg level, Baseline HBsAg level, Antiviral treatment, Serum ALT level
      • Xi'an, Shaanxi, China
        First Affiliated Hospital of Xi'an Jiaotong University
      Aug 20, 2021

      Hepatitis B Trial in Mwanza (HBSAg (sure screen test))

      Completed
      Has Results
      • Hepatitis B
      • HBSAg (sure screen test)
      • Mwanza, Tanzania
        Bugando Medical Center
      Oct 23, 2020

      Chronic Hepatitis B Trial in Amsterdam (Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir

      Completed
      • Chronic Hepatitis B
      • Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarate
      • Amsterdam, Noord-Holland, Netherlands
        Academic Medical Center
      Mar 25, 2021